Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Erlotinib 100 mg tablets are an oral, targeted cancer therapy used to treat NSCLC and pancreatic cancer by inhibiting the Epidermal Growth Factor Receptor (EGFR) tyrosine kinase, preventing cancer cell growth. It has 60–100% bioavailability (increased by food), a 36-hour half-life, and requires empty-stomach administration for optimal, consistent absorption.
| Strength | 100mg |
| Packaging Size | 30 tablets |
| Storage | 15°C to 30°C. |
| Uses | Non-small cell lung cancer and pancreatic cancer. |
| Main Ingedients | Erlotinib |